Caxton Associates (New York)’s Medifast MED Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,170	Closed	-$536K	–	593
2023 Q1	$536K	Buy	+5,170	New	+$573K	0.09%	246
2022 Q2	–	Sell	-1,396	Closed	-$238K	–	672
2022 Q1	$238K	Buy	1,396 +157	+13%	+$29.6K	0.02%	407
2021 Q4	$259K	Buy	1,239 +78	+7%	+$16.1K	0.03%	451
2021 Q3	$224K	Sell	1,161 -1,698	-59%	-$417K	0.03%	380
2021 Q2	$809K	Buy	2,859 +585	+26%	+$159K	0.11%	97
2021 Q1	$482K	Buy	+2,274	New	+$544K	0.05%	169
2020 Q4	–	Sell	-2,388	Closed	-$393K	–	253
2020 Q3	$393K	Buy	+2,388	New	+$393K	0.04%	144
2018 Q3	–	Sell	-2,104	Closed	-$337K	–	507
2018 Q2	$337K	Buy	+2,104	New	+$269K	0.04%	301
2017 Q2	–	Sell	-10,637	Closed	-$472K	–	545
2017 Q1	$472K	Buy	+10,637	New	+$458K	0.04%	263